BioSpace News Archive

Drug Development

Six Life Sciences Successes and Failures To Kick Off 2021

2021 is off to a hopeful start for some companies, executives and scientists, while others are forced to fold programs and recalibrate.

January 5, 2021
·
6 min read
·
Heather McKenzie
Pharm Country

Top Life Science Startups to Watch in 2021

BioSpace is proud to present its NextGen Bio “Class of 2021,” a list of up-and-coming life science startups in North America that recently launched.

January 5, 2021
·
16 min read
·
Mark Terry
Policy

FDA: Don’t Mess with the COVID-19 Vaccine Doses

The U.S. FDA came out to warn health care personnel not to make any changes to the dosing of the vaccines and that doing so would place the public health at risk and undermine “the historic vaccination effort to protect the population.”

January 5, 2021
·
4 min read
·
Mark Terry
Chemo Drug Potentially More Potent than Remdesivir Against Coronavirus

Researchers with Shenzhen Institutes of Advanced Technology in China used a variety of computational techniques to simulate drug-virus interactions. They then screened 1,906 existing drugs to evaluate which ones might inhibit replication of SARS-CoV-2, the virus that causes COVID-19.

January 5, 2021
·
3 min read
·
Mark Terry
BioCapital

Two Companies Ring in 2021 with Cash for Cancer and Rare Diseases

In the first week of the new year, two companies raised more than $150 million in separate Series A financing rounds to fund research programs aimed at developing treatments for cancer and rare diseases.

January 5, 2021
·
3 min read
·
Alex Keown
BioCapital

Moderna Raises Vaccine Manufacturing Goals and Other COVID-19 News

With COVID-19 still running rampant across the globe, Moderna announced it will rapidly expand its vaccine manufacturing operations in order to meet demand in the countries where the medication has received emergency authorization.

January 5, 2021
·
4 min read
·
Alex Keown
Business

Fujifilm Diosynth Opening Viral Vector Manufacturing Plant Near Boston

The new process development and manufacturing facility will focus on viral vectors and advanced therapies. It is the third location for Diosynth’s CDMO viral vector services.

January 5, 2021
·
3 min read
·
Mark Terry
Biotech Beach

Could Fluoride be the Solution to Antibiotic Resistance? A New Study Weighs In

Scientists at the University of California (UC), Santa Barbara, believe fluoride may offer hope in the fight against antibiotic-resistant bacteria.

January 5, 2021
·
3 min read
·
Brandon May
Biotech Bay

Terns Rakes in $87 Million for NASH Pipeline

Terns Pharmaceuticals announced today that it had concluded an $87 million round of Series C financing.

January 5, 2021
·
3 min read
·
Krystle Vermes
Business

Cell Therapy Speed and Efficiency Driven by Draper’s New Way of Thinking

Draper, a not-for-profit research and development organization, is speeding the process with new tools designed specifically to produce cell therapies at scale.

January 5, 2021
·
4 min read
·
Gail Dutton